MedTrace Logo

Efficacy of Blue Light Treatment in Patients With Nonseasonal Major Depressive Disorder

NCT04555408 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2020-09-18

No results posted yet for this study

Summary

To compare the efficacy of blue light, bright light and dim light in the treatment of with nonseasonal major depression disorder(MDD) in adults.

Conditions

Interventions

DEVICE

blue light

Patients receive exposure to 100lux blue light, which dominant wave-length is 468nm for 30 minutes in the morning.

DEVICE

bright light

Patients receive exposure to 1000lux bright light, which dominant wave-length is 490nm for 30 minutes in the morning.

DEVICE

dim light

Patients receive exposure to 100lux dim light, which dominant wave-length is 490nm for 30 minutes in the morning.

Sponsors & Collaborators

  • Shanghai Mental Health Center, Jingan District

    collaborator OTHER

  • Shanghai Mental Health Center, Yangpu District

    collaborator UNKNOWN

  • Fudan University

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Yuan Wang, MD · Shanghai Zhongshan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-10-31
Completion
2022-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04555408 on ClinicalTrials.gov